Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
This track will explore the latest developments in immunotherapy approaches for various cancer types. Emphasis will be placed on novel therapeutic agents and their mechanisms of action in enhancing anti-tumor immunity.
This session focuses on the translation of laboratory research into clinical practice, highlighting successful case studies and ongoing challenges. Participants will discuss strategies to enhance the efficacy of translational research in oncology.
This track will delve into the molecular and cellular mechanisms underlying tumor biology, including genetic and epigenetic factors. Discussions will center on identifying novel therapeutic targets for intervention.
This session will examine the role of precision medicine in personalizing cancer treatment based on individual patient profiles. Topics will include genomic profiling, biomarker discovery, and the impact on treatment outcomes.
This track will highlight cutting-edge research methodologies and technologies in cancer research. Presentations will cover topics such as high-throughput screening, CRISPR technology, and bioinformatics applications.
This session will address the importance of patient-centered care in oncology, focusing on strategies to improve quality of life for cancer patients. Discussions will include psychosocial support, palliative care, and survivorship issues.
This track will explore the intersection of health policy and oncology, examining how policies influence cancer research funding, access to care, and treatment guidelines. Participants will discuss advocacy strategies for improving cancer care delivery.
This session will cover the latest trends in cancer treatment modalities, including targeted therapies, chemotherapeutics, and radiation techniques. Emphasis will be placed on integrating new treatments into standard care practices.
This track will investigate the role of the tumor microenvironment in cancer progression and therapy resistance. Discussions will include interactions between tumor cells and stromal components, as well as potential therapeutic implications.
This session will focus on the design and implementation of clinical trials in oncology, addressing regulatory hurdles and ethical considerations. Participants will share insights on improving trial efficiency and patient recruitment.
This track will examine global strategies for cancer control and prevention, highlighting successful public health initiatives and community-based interventions. Discussions will focus on addressing disparities in cancer outcomes across different populations.